Septerna, Inc. (NASDAQ:SEPN) People
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Rajeev M Shah Other companies: Freenome, Inc. (Director · Since at least Jul 20, 2026); Parabilis Medicines, Inc. (Director · Since at least Jun 9, 2026); Hemab Therapeutics Holdings, Inc. (Director · Since at least Apr 30, 2026); SpyGlass Pharma, Inc. (Director · Since at least Feb 5, 2026); Evommune, Inc. (Director · Since at least Nov 5, 2025); Sionna Therapeutics, Inc. (Director · Since at least Feb 6, 2025); Bicara Therapeutics Inc. (Director · Since at least Sep 12, 2024); Artiva Biotherapeutics, Inc. (Director · Since at least Jul 18, 2024); Cidara Therapeutics Inc (Director · Since at least Apr 24, 2024); LENZ Therapeutics, Inc. (Director · Since at least Mar 21, 2024); Mineralys Therapeutics, Inc. (Director · Since at least Feb 9, 2023); Acrivon Therapeutics, Inc. (Director · Since at least Nov 9, 2022); ARS Pharmaceuticals, Inc. (Director · Since at least Nov 8, 2022); PepGen Inc. (Director · Since at least May 5, 2022); Nkarta, Inc. (Director · Since at least Feb 14, 2022); Tyra Biosciences, Inc. (Director · Since at least Sep 14, 2021); Wave Life Sciences Ltd. (Director · Since at least Aug 16, 2021); Climb Bio, Inc. (Director · Since at least Aug 9, 2021); Acumen Pharmaceuticals, Inc. (Director · Since at least Jun 30, 2021); Janux Therapeutics, Inc. (Director · Since at least Jun 10, 2021); Vor Biopharma Inc. (Director · Since at least Feb 4, 2021); 89bio Inc (Director · Since at least Nov 8, 2019); Iteos Therapeutics Inc (Director · Jun 9, 2022 – Jun 9, 2022 · Past); Forma Therapeutics Holdings Inc (Director · Jun 8, 2022 – Jun 8, 2022 · Past); Icosavax Inc (Director · Jul 28, 2021 – Feb 19, 2024 · Past); Cytek Biosciences, Inc. (Director · Jul 22, 2021 – Mar 14, 2022 · Past); Jade Biosciences, Inc. (Director · Jun 29, 2021 – Jun 17, 2024 · Past); POINT Biopharma Global Inc (Director · Jun 23, 2021 – Jun 29, 2021 · Past); Werewolf Therapeutics, Inc. (Director · Apr 29, 2021 – May 12, 2025 · Past); Orchard Therapeutics PLC (Director · Feb 9, 2021 – Feb 9, 2021 · Past); Black Diamond Therapeutics, Inc. (Director · Jan 29, 2020 – Jul 5, 2023 · Past); Satsuma Pharmaceuticals Inc (Director · Sep 12, 2019 – Jun 6, 2023 · Past); Eidos Therapeutics Inc (Director · Jun 19, 2018 – May 27, 2020 · Past); Solid Biosciences Inc. (Director · Jan 25, 2018 – Jan 11, 2024 · Past); Kala Bio, Inc. (Director · Jul 19, 2017 – Jun 17, 2021 · Past); KalVista Pharmaceuticals, Inc. (Director · Nov 21, 2016 – Oct 12, 2017 · Past); Ra Pharmaceuticals Inc (Director · Oct 25, 2016 – Apr 2, 2020 · Past) | Director · Since at least Oct 24, 2024 |
| Shalini Sharp Other companies: Iambic Therapeutics, Inc. (Board Member · Since at least Nov 5, 2026); BeOne Medicines Ltd. Class A (Director · Since at least Jun 11, 2026); Organon & Co. (Director · Since at least May 14, 2021); Neurocrine Biosciences, Inc. (Director · Since at least Feb 1, 2020); Nuvation Bio Inc. (Director · Jun 30, 2020 – Feb 10, 2021 · Past); Precision BioSciences, Inc. (Director · Mar 27, 2019 – May 10, 2021 · Past); Sutro Biopharma, Inc. (Director · Nov 8, 2018 – Jun 6, 2022 · Past); Ultragenyx Pharmaceutical Inc. (EVP, Finance · Jan 30, 2014 – Oct 14, 2020 · Past); Agenus Inc. (Director · Oct 1, 2006 – Mar 2, 2018 · Past) | Director · Since at least Oct 24, 2024 |
| Rajiv Patni Other companies: BioXcel Therapeutics, Inc. (Director · Since at least Jan 15, 2025); Quince Therapeutics, Inc. (Director · Since at least Feb 15, 2024); Reata Pharmaceuticals Inc (EVP, Chief R&D Officer · Jun 12, 2023 – Sep 26, 2023 · Past); Portola Pharmaceuticals Inc (EVP, CMO · Feb 3, 2020 – Jul 2, 2020 · Past); Adamas Pharmaceuticals Inc (Chief Medical Officer · Jun 8, 2015 – Apr 8, 2019 · Past); Ocera Therapeutics Inc (Chief Development Officer · Sep 2, 2014 – May 7, 2015 · Past) | Chief Medical Officer · Since at least Aug 24, 2026 |
| Jeffrey Tong Other companies: Maze Therapeutics, Inc. (Director · Jan 30, 2025 – Jan 30, 2025 · Past); Rapport Therapeutics, Inc. (Director · Jun 6, 2024 – Jun 6, 2024 · Past); Nurix Therapeutics, Inc. (Director · Jul 23, 2020 – May 6, 2021 · Past) | Chairman of the Board · Since at least Oct 24, 2024 |
| Keith Gottesdiener Other companies: Prime Medicine, Inc. (See Remarks, Director · Oct 19, 2022 – May 8, 2025 · Past); Rhythm Pharmaceuticals, Inc. (CEO & President, Director · Oct 4, 2017 – Mar 9, 2020 · Past); Intercept Pharmaceuticals Inc (Director · Jul 19, 2016 – Nov 8, 2023 · Past) | Director · Since at least Sep 25, 2025 |
| Liz Bhatt Other companies: eFFECTOR Therapeutics Inc (Director · Aug 25, 2021 – Jun 13, 2024 · Past); Applied Molecular Transport Inc (Chief Bus. & Strategy Officer · Jun 4, 2020 – Feb 15, 2022 · Past); Achaogen Inc (Chief Operating Officer · Jul 26, 2018 – Feb 21, 2019 · Past) | President and Chief Operating Officer · Since at least Oct 24, 2024 |
| Alan Ezekowitz Other companies: Organon & Co. (Director · Since at least Jun 2, 2021); Fulcrum Therapeutics, Inc. (Director · Since at least Jul 17, 2019) | Director · Since at least Oct 24, 2024 |
| Gil Labrucherie Other companies: Rezolute, Inc. (Director · Since at least Jan 23, 2024); Acelyrin, Inc. (CFO and CBO · Oct 4, 2023 – Aug 31, 2024 · Past) | Chief Financial Officer · Since at least Jan 6, 2025 |
| Jae B Kim Other companies: Design Therapeutics, Inc. (Chief Medical Officer · Mar 13, 2024 – Mar 13, 2024 · Past); Avidity Biosciences, Inc (Chief Medical Officer · Jul 27, 2020 – Feb 2, 2021 · Past) | Chief Medical Officer · Since at least Oct 24, 2024 |
| Bernard Coulie Other companies: Pliant Therapeutics, Inc. (Director · Since at least Jun 2, 2020) | Director · Since at least Oct 24, 2024 |
| Jake Simson Other companies: Janux Therapeutics, Inc. (Director · Since at least Jun 11, 2026) | Director · Since at least Nov 5, 2026 |
| Abraham Bassan | Director · Since at least Nov 5, 2026 |
| Daniel Long | Senior Vice President, Drug Discovery · Since at least Oct 24, 2024 |
| Jeffrey Finer | Chief Executive Officer, Director · Since at least Apr 2, 2025 |
| Mark A. Wilson | Chief Legal Officer · Since at least Jan 8, 2026 |
| Ran Xiao | Interim CFO · Oct 24, 2024 – Oct 24, 2024 · Past |
| Samira Shaikhly | Chief People Officer · Since at least Oct 24, 2024 |
| Uwe Klein | Senior Vice President, Biological Sciences · Since at least Aug 7, 2025 |